Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment
BACKGROUND: Adoptive immunotherapy with cytotoxic T lymphocytes (CTL) represents an alternative approach to treating solid tumors. Ideally, this would confer long-term protection against tumor. We previously demonstrated that in vitro-generated tumor-specific CTL from the ovalbumin (OVA)-specific OT...
Guardat en:
| Publicat a: | BMC Cancer |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC183847/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12882650/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2407-3-21 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|